Watson, C., Bradley, J., Friend, P., Firth, J., Taylor, C., Bradley, J., . . . Calne, R. (2005). Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
Chicago-čujuhus (17. p.)Watson, C., et al. Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation--efficacy and Safety at Five Years. 2005.
MLA-čujuhus (9. p.)Watson, C., et al. Alemtuzumab (CAMPATH 1H) Induction Therapy in Cadaveric Kidney Transplantation--efficacy and Safety at Five Years. 2005.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.